By Robert Lang
Take a long, hard look at yourself -- and at the Fed.
The company was never as bad as it was once perceived to be.
Biotech M&A deals that haven't happened because of price argue against the risk of a bubble.
Acquisition Expected to Close Today
Trade-Ideas LLC identified Onyx Pharmaceuticals (ONXX) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
Cramer will be watching Washington and a number of stocks.
Some of your predictions were spot on, others not so much.
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Onyx Pharmaceuticals (“Onyx”...
There's nothing to like about today's down market, especially when it doesn't reflect all the bad news, Cramer said.
Rigrodsky & Long, P.A.
Levi & Korsinsky is investigating the Board of Directors of Onyx Pharmaceuticals, Inc.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV